about
The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphataseAngiotensin-converting enzyme is involved in outside-in signaling in endothelial cellsInsulin induces the release of vasodilator compounds from platelets by a nitric oxide-G kinase-VAMP-3-dependent pathwaySignaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIAThe F-BAR protein NOSTRIN participates in FGF signal transduction and vascular development.Nitric oxide-induced activation of the AMP-activated protein kinase α2 subunit attenuates IκB kinase activity and inflammatory responses in endothelial cellsThe pharmacology of the cytochrome P450 epoxygenase/soluble epoxide hydrolase axis in the vasculature and cardiovascular diseaseWhatever happened to the epoxyeicosatrienoic Acid-like endothelium-derived hyperpolarizing factor? The identification of novel classes of lipid mediators and their role in vascular homeostasisCytochrome P4502S1: a novel monocyte/macrophage fatty acid epoxygenase in human atherosclerotic plaquesAnnexing AXLHypoxic pulmonary vasoconstriction requires connexin 40-mediated endothelial signal conduction.NO: the primary EDRF.Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition.Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats.Phosphorylation of Thr(495) regulates Ca(2+)/calmodulin-dependent endothelial nitric oxide synthase activity.Increased cytochrome P4502E1 expression and altered hydroxyeicosatetraenoic acid formation mediate diabetic vascular dysfunction: rescue by guanylyl-cyclase activation.Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice.Cytochrome P450 2C is an EDHF synthase in coronary arteries.The factor in EDHF: Cytochrome P450 derived lipid mediators and vascular signaling.Isometric contraction induces the Ca2+-independent activation of the endothelial nitric oxide synthase.Methylglyoxal induces platelet hyperaggregation and reduces thrombus stability by activating PKC and inhibiting PI3K/Akt pathway.Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase.Regulation of endothelium-derived vasoactive autacoid production by hemodynamic forces.An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice.Cytochrome P450 epoxygenases as EDHF synthase(s).Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodelingEpoxyeicosatrienoic acids and endothelium-dependent responses.Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols.Nucleotide excision DNA repair is associated with age-related vascular dysfunctionFrom endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: Epoxyeicosatrienoic acids (EETs) and cell signaling.Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedsideSignaling by the angiotensin-converting enzyme.The atherosusceptible endothelium: endothelial phenotypes in complex haemodynamic shear stress regions in vivo.Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis.Vascular cytochrome p450 enzymes: physiology and pathophysiology.Anaphylactic shock depends on endothelial Gq/G11.Mena/VASP and αII-Spectrin complexes regulate cytoplasmic actin networks in cardiomyocytes and protect from conduction abnormalities and dilated cardiomyopathy.Differential effects of EPA versus DHA on postprandial vascular function and the plasma oxylipin profile in menInhibition of the soluble epoxide hydrolase by tyrosine nitration.Müller glia cells regulate Notch signaling and retinal angiogenesis via the generation of 19,20-dihydroxydocosapentaenoic acid.
P50
Q24294364-85F29E06-46A3-46CA-99AD-0102CB7E296BQ24299714-0E286D45-09EF-465F-AB60-6BE9DB5B5986Q24306460-889E251F-7745-4BA6-BB40-B12A44DD8353Q24336883-1BF9226F-F8A2-451F-B0CF-DFC161152EE8Q24339432-5B633D46-BF80-4253-BBA7-9EFA54BB8EDDQ27335298-FC10A97D-89B0-4732-B610-AF0CF077CF29Q28248474-051A7DD5-BDBE-4CAE-A75C-83DE9CBF98F2Q28250009-3D7D2D2A-1BE6-4E5B-BB21-569D41DEE8F3Q28281019-ECA1A893-22B7-4F38-80EC-C697930A350BQ28595397-D3584400-BB33-41BE-9772-8F77883B33DFQ30423020-E8686F0C-BC22-45BA-A98D-BB4AD4302152Q33540177-FF0DED1B-00A6-4CB7-975F-5EAC5714626BQ33814824-AE2E5112-C69D-431A-B238-5279179F286CQ33824233-40C441F8-F169-433E-A771-BF9C54A14B4CQ33950554-28F2B12E-CC82-4029-BF44-A97BDA4577BFQ34024378-A864CFB4-F953-4CC3-9213-C246BCE5FF75Q34056717-360052AD-7810-4877-9706-4028670B0925Q34175614-04110286-4A48-41CA-83B4-EFE9599F7BA9Q34518126-BE6EBD17-9DFD-47B9-B1EA-B44875500A53Q34959141-D081AC28-CC98-4834-85C8-1D69DA9AC4E2Q34994655-59B82963-F0EA-4A50-A832-8FCC37CE3909Q35026148-50F28F2F-D694-4EAE-9A05-071598198B04Q35033293-54D182CA-FE68-4F8C-9F45-5D473D9F1639Q35214463-B5171DCA-685B-4191-8A48-C2AD35398E0DQ35693556-D30129CF-7699-46C6-BF8D-ED2BE57C1292Q36012729-21CF2408-3587-43DA-974E-752A1D03344AQ36027656-A5D4E55B-BDAC-4140-8117-785A24822654Q36056415-B505D360-4AFD-4E45-80E5-878A2836E0EDQ36198670-61EE9274-9D83-43C8-A416-2EE593CB73F2Q36354430-8123CB83-A2D0-4A5D-8C1C-C28B32152614Q36371672-C30ECCB4-7816-4260-B684-BF2DC21EC780Q36449066-5ACFC933-0221-419C-87E4-7E2F2B5134E7Q36964212-0F25B390-3044-447C-B08E-07DFC9D47CD5Q36977680-A0EC3D89-0056-498B-8310-BF20C1F2C825Q37060993-1FA388AA-088E-424C-B73C-DC536CCAF77FQ37106765-7CCBE14D-3FCE-422D-BB20-5F1E93CFC473Q37116252-658971FB-C62F-440C-8D60-EE8A2BD641DEQ37213436-D06C0633-8DE6-4963-8597-0777D83ADB7FQ37459953-D2C2420C-AA29-406C-BE66-BD61A44A4795Q37576699-2779EDBA-2BBB-4AEA-B9BA-5F51498359F4
P50
description
hulumtuese
@sq
molecular medicine researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Ingrid Fleming
@ast
Ingrid Fleming
@en
Ingrid Fleming
@es
Ingrid Fleming
@nl
Ingrid Fleming
@sl
type
label
Ingrid Fleming
@ast
Ingrid Fleming
@en
Ingrid Fleming
@es
Ingrid Fleming
@nl
Ingrid Fleming
@sl
prefLabel
Ingrid Fleming
@ast
Ingrid Fleming
@en
Ingrid Fleming
@es
Ingrid Fleming
@nl
Ingrid Fleming
@sl
P1053
L-1225-2014
P106
P21
P31
P3829
P496
0000-0003-1881-3635